AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
A once-monthly extended-release formulation of naltrexone (Vivitrol) delivered by intramuscular injection was approved by the FDA on October 12. Vivitrol is indicated for treatment and relapse …